Contineum Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Contineum Therapeutics has a total shareholder equity of $210.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $216.0M and $5.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$213.91m |
| Equity | US$210.23m |
| Total liabilities | US$5.81m |
| Total assets | US$216.03m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: CTNM's short term assets ($215.1M) exceed its short term liabilities ($5.8M).
Long Term Liabilities: CTNM has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CTNM is debt free.
Reducing Debt: CTNM had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CTNM has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: CTNM has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 11.1% each year